MedTrace Logo

Automated Myocardial Performance Index Using Samsung HERA W10

NCT04140669 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2022-07-13

No results posted yet for this study

Summary

Researchers are using Myocardial performance index (MPI) to assess fetal cardiac function before, during, and after fetal surgery in order to gain more knowledge about fetal cardiac function in high risk pregnancies and the relationship to outcomes of fetal surgical interventions.

Conditions

  • Twin to Twin Transfusion Syndrome
  • Congenital Diaphragmatic Hernia
  • Neural Tube Defects
  • Lower Urinary Tract Infection

Interventions

DEVICE

Automated Myocardial Performance Index (MPI)

Automated Myocardial Performance Index will be performed using Samsung HERA W10 prior too fetal surgical interventions, during surgery, and following surgery.

Sponsors & Collaborators

Principal Investigators

  • Rodrigo Ruano, MD, PhD · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-16
Primary Completion
2020-07-07
Completion
2020-07-07
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04140669 on ClinicalTrials.gov